Evidence map›Paper›PMID 41831541›Full record

ArticleNeuroImage2026

An explainable framework for the relationship between dementia and metabolism patterns.

C Vázquez-García, F J Martínez-Murcia, F Segovia, A Forte, J Ramírez, I Illán, A Hernández-Segura, C Jiménez-Mesa, J M Górriz, Alzheimer’s Disease Neuroimaging Initiative

Abstract read
PubMed Publisher
In one paragraph

Article in NeuroImage, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

C Vázquez-GarcíaDepartment of Signal Processing and Biomedical Applications, University of Granada, Granada 18071, Spain. Electronic address: crisvgarcia@ugr.es.
F J Martínez-MurciaDepartment of Signal Processing and Biomedical Applications, University of Granada, Granada 18071, Spain. Electronic address: fjesusmartinez@ugr.es.
F SegoviaDepartment of Signal Processing and Biomedical Applications, University of Granada, Granada 18071, Spain. Electronic address: fsegovia@ugr.es.
A ForteDepartment of Statistics and Operations Research, University of Valencia, Valencia 46010, Spain. Electronic address: anabel.forte@uv.es.
J RamírezDepartment of Signal Processing and Biomedical Applications, University of Granada, Granada 18071, Spain. Electronic address: javierrp@ugr.es.
I IllánDepartment of Signal Processing and Biomedical Applications, University of Granada, Granada 18071, Spain. Electronic address: illan@ugr.es.
A Hernández-SeguraDepartment of Signal Processing and Biomedical Applications, University of Granada, Granada 18071, Spain. Electronic address: alejandrohs@ugr.es.
C Jiménez-MesaDepartment of Communication Engineering, University of Malaga, 29071, Spain. Electronic address: carmenj@uma.es.
J M GórrizDepartment of Signal Processing and Biomedical Applications, University of Granada, Granada 18071, Spain. Electronic address: gorriz@ugr.es.
Alzheimer’s Disease Neuroimaging Initiative

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-dimensional neuroimaging data poses a challenge for the clinical assessment of neurodegenerative diseases, as it involves complex non-linear relationships that are difficult to disentangle using traditional methods. Variational Autoencoders (VAEs) provide a powerful framework for encoding neuroimaging scans into lower-dimensional latent spaces that capture meaningful disease-related features. In this work, we propose a semi-supervised VAE framework that incorporates a flexible similarity regularization term designed to align selected latent variables with clinical or biomarker measures related to dementia progression. This approach allows adapting the similarity metric and the supervised variables according to specific goals or available data. We demonstrate the framework using Positron Emission Tomography (PET) scans from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database, guiding the model to capture neurodegenerative patterns associated with Alzheimer's Disease (AD) by maximizing the similarity between the first latent dimension with a clinical cognitive score, and the second dimension with age. Leveraging the first supervised latent variable, we generate average reconstructions corresponding to different levels of cognitive impairment. A voxel-wise General Linear Model (GLM) confirms reduced metabolism in key brain regions, predominantly in the hippocampus, and within major Resting State Network (RSN)s, particularly the Default Mode Network (DMN) and the Central Executive Network (CEN). Further examination of the remaining latent variables show that they encode affine transformations-rotation, translation, and scaling-as well as intensity variations, capturing common confounding factors such as inter-subject variability and site-related noise. Our findings indicate that the framework effectively disentangles this neuroimaging biomarker (z

Indexed as

Alzheimer DiseaseBrainDementiaNeuroimagingPositron-Emission TomographyAgedAged, 80 and overAutoencoderFemaleHumansMaleADNIAlzheimerComputational neurosciencePETVariational Autoencoder

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.